Callan Family Office Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$109M |
| 2 |
Vanguard Russell 3000 ETF
VTHR
|
+$68.2M |
| 3 |
NVIDIA
NVDA
|
+$43.4M |
| 4 |
Microsoft
MSFT
|
+$35.4M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$31.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$3.75M |
| 2 |
Charter Communications
CHTR
|
+$2.66M |
| 3 |
Comcast
CMCSA
|
+$2.58M |
| 4 |
International Flavors & Fragrances
IFF
|
+$2.18M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$1.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.06% |
| 2 | Technology | 22.93% |
| 3 | Financials | 13.36% |
| 4 | Healthcare | 9.15% |
| 5 | Industrials | 7.57% |
Similar funds
Callan Family Office's Q4 2025 Portfolio in Review
As of Q4 2025, Callan Family Office held 1,130 positions worth $4.65B, up 48% from $3.14B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Callan Family Office deployed $1.42B of net new capital in Q4 2025, opening 282 new positions and adding to 733 existing holdings. Its largest new stake was Vanguard Russell 3000 ETF: 228,815 shares worth $68.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Fiserv Inc, an estimated $3.75M trimmed.
- Callan Family Office's largest Q4 2025 buy was Vanguard Russell 3000 ETF: 228,815 shares worth $68.7M.
- Callan Family Office added most to Vanguard S&P 500 ETF in Q4 2025, an estimated $109M increase.
- Callan Family Office's biggest Q4 2025 reduction was Fiserv Inc, cutting an estimated $3.75M.
- Callan Family Office fully exited HubSpot in Q4 2025, selling an estimated $1.16M.
- Callan Family Office's ten largest holdings make up 26% of its $4.65B portfolio in Q4 2025.
- Callan Family Office opened 282 new positions and closed 19 in Q4 2025.
- Callan Family Office's portfolio value rose 48% quarter-over-quarter to $4.65B.
Based on Callan Family Office's 13F filing for Q4 2025, filed 12 Feb 2026.